1 Min Read
Dec 14 (Reuters) - Valeant Pharmaceuticals International Inc CEO Joe Papa, speaking at BMO investor conference in New York:
* Said Valeant plans to invest in its Salix business, a core asset Further company coverage: (Reporting By Rod Nickel)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.